BMY   $63.06  0.35% Market Closed After Close 63.0165 -0.07%

Bristol-Myers Squibb Company

EMA (20): 2026-09-08 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

EMA (100): 2026-07-07 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

Trend Type up and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -2.86%
EMA (20) date of signal Sept. 8, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -1.19%
EMA (50) date of signal Sept. 16, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 8.40%
EMA (100) date of signal July 7, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -1.40%
RSI (14) date of signal Sept. 15, 2026, 3 a.m.
MACD Signals bearish
MACD Yield -1.19%
MACD date of signal Sept. 16, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.0
Stochastic date of signal Sept. 17, 2026, 3 a.m.
Updated Sept. 18, 2026, 11 p.m.